Myriad Genetics Inc (NASDAQ:MYGN)

25.39
BATS BZX Real-Time Price
As of 10:38am ET
 +0.37 / +1.48%
Today’s Change
20.10
Today|||52-Week Range
48.40
-12.66%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 22.00, with a high estimate of 28.00 and a low estimate of 18.00. The median estimate represents a -13.35% decrease from the last price of 25.39.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.31
Sales
$209.6M
Reporting Date
Feb 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 282.81%
 
 
 
 
 
 
Growthannually -37.80%
 
 
 
 
 
 

Sales

Growthquarterly 12.52%
 
 
 
 
 
 
Growthannually -5.13%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.